ACET · NASDAQ · Biotechnology

Adicet Bio (ACET)

Develops off-the-shelf gamma delta CAR-T cell therapies for autoimmune disease and cancer.

$9.31
After hours+0.22 (+2.42%)
At close$9.09(+1.79%)
  1. Adicet Bio (ACET) Upgraded to Buy: Here's Why

    Zacks Investment Research